Zhuang, Guiwu
Zhang, Xiaotao
Du, Wenjing
Xu, Libin
Ma, Jiyong
Luo, Haitao
Tang, Hongzhen
Wang, Wei
Wang, Peng
Li, Miao
Yang, Xu
Wu, Dongfang
Fang, Shencun https://orcid.org/0000-0002-4223-5428
Funding for this research was provided by:
Scientific Research Project of Cancer Foundation of China (CFC-XGB-202201)
Clinical Research Fund of Wu Jieping Medical Foundation (320.6750.2020-10-27)
CSCO-Shiyao Tumor Research Fund (Y-SY201901-0056)
CSCO-Junshi Tumor Immunology Research Fund (Y-JS2019-017)
Article History
Received: 28 September 2023
Accepted: 6 January 2024
First Online: 16 January 2024
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of Nanjing Chest Hospital. Written informed consent was obtained from all participants. The ethical approval number was 2021-KL025-01.
: Not applicable.
: The authors declare no conflict of interest.